Year | 2003 | 2005 | ||
No. communities | 29 | 17 | ||
No. children swabbed | 902 | 818 | ||
Children (%) | Risk Difference | P | ||
Vaccinated (>1 dose) | 87% | 96% | 9% [7,12] | 0.0000 |
Vaccinated (primary) | 76% | 84% | 9% [5,12] | 0.0000 |
Vaccinated (primary+23v) | 35% | 62% | 27% [22,31] | 0.0000 |
Spn (% children) | 82% | 76% | -6% [-10,-2] | 0.002 |
0–6 mo n = 83 | 83% | 74% | -9.7 [-28,8] | 0.3098 |
6–12 mo n = 220 | 80% | 78% | -1.6 [-13,10] | 0.7791 |
12–24 mo n = 477 | 84% | 76% | -8.2 [-16, -0.2] | 0.0331 |
24–48 mo n = 597 | 84% | 78% | -5.3 [-12,1] | 0.0989 |
48- n = 343 | 77% | 74% | -2.9 [-13,7] | 0.5677 |
7PCV-type | 11% | 8% | -4% [-6, -0.1] | 0.0105 |
23PPV-type | 42% | 33% | -9% [-14,-5] | 0.0001 |
23PPV-type, non-7PCV | 31% | 25% | -6% [-10,-2] | 0.0061 |
19A | 12% | 9% | -3% [-6,-1] | 0.0196 |
Non-23PPV | 57% | 67% | 9% [5,14] | 0.0001 |
6A | 4% | 2% | -1.5% [-3,0.1] | 0.0712 |
6C | 4% | 4% | 0% [-2,2] | 0.9634 |
16F | 12% | 10% | -2% [-5,1] | 0.1343 |
Prescribed beta-lactam | 14% | 16% | 1% [-2,5] | 0.4763 |
Penicillin non-susceptible (MIC ≥ 0.12 μg/mL) | 17% | 14% | -3% [-6,0.4] | 0.0899 |
Prescribed macrolide | 1% | 6% | 5% [3,7] | 0.0000 |
Azithromycin resistant (MIC ≥ 2 μg/mL) | 5% | 6% | 1% [-1,3] | 0.4888 |
Azithromycin resistant (MIC ≥ 32 μg/mL) | 4% | 3% | -1% [-3,1] | 0.2328 |